Back to search

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status

Data up to Jan 2025

Published2005
Citations65
References34

Total Citations Per Year

Abstract

References (34)

Mutations of the BRAF gene in human cancer

2002 • 10,249 citations

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

2004 • 2,674 citations

High frequency of BRAF mutations in nevi

2002 • 1,701 citations

RAF/RAS oncogenes and mismatch-repair status

2002 • 1,205 citations

The RAF proteins take centre stage

2004 • 1,158 citations

BRAF Mutation in Papillary Thyroid Carcinoma

2003 • 915 citations

Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma

2003 • 829 citations

Determinants of BRAF Mutations in Primary Melanomas

2003 • 653 citations

Distinct requirements for Ras oncogenesis in human versus mouse cells

2002 • 425 citations

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

2003 • 301 citations

Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?

2004 • 299 citations

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low‐grade serous tumours

2004 • 233 citations

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma

2003 • 215 citations

BRAF mutations in metastatic melanoma: a possible association with clinical outcome.

2003 • 208 citations

Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors

2004 • 199 citations

Switching on kinases: oncogenic activation of BRAF and the PDGFR family

2004 • 180 citations

Ras–effector interactions: after one decade

2003 • 177 citations

Conferring specificity on the ubiquitous Raf/MEK signalling pathway

2004 • 162 citations

BRAF Point Mutations in Primary Melanoma Show Different Prevalences by Subtype

2004 • 97 citations

K- ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome

1998 • 45 citations

B-Raf and Ha-ras mutations in chemically induced mouse liver tumors

2004 • 42 citations

B-Raf Is Dispensable for K-Ras-Mediated Oncogenesis in Human Cancer Cells

2004 • 33 citations

RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers

2004 • 31 citations

Evaluation and Comparison of Histopathologic Grading Systems of Epithelial Carcinoma of the Uterine Cervix

1994 • 28 citations

High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears.

1999 • 25 citations

Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma

2003 • 22 citations

Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors

2004 • 20 citations

K-ras exon 2 point mutations in human endometrial cancer

2001 • 17 citations

K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix

2002 • 16 citations

“Low-risk” and “High-risk” HPV-infection and K-ras Gene Point Mutations in Human Cervical Cancer

2001 • 15 citations

Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix

1998 • 13 citations

Emerging issues of the expression profiling technologies for the study of gynecologic cancer

2005 • 10 citations

Human Papilloma Virus Infection and Ki-rasOncogene in Paraffin-Embedded Squamous Carcinomas of the Cervix

1993 • 9 citations

“Low-risk” and “High-risk” HPV-infection and K-ras Gene Point Mutations in Human Cervical CancerA Study of 31 Cases

2001 • 5 citations

Cited By (0)

No citing papers found in database

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS… (2005) – Gynecologic Oncology | Metascience Observatory Explorer